JAMA Oncology Author Interviews

Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

Proportional Sedation for Persistent Agitated Delirium in Palliative Care

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury

Accelerated Aging in Survivors of Childhood Cancer

Academic-Community Partnership and Deaths in Promyelocytic Leukemia

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

Identification of Immune Checkpoint Inhibitor–Induced Diabetes

Neoadjuvant Exercise Therapy in Prostate Cancer

Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

Atezolizumab in Combination With Carboplatin in Metastatic TNBC

Shorter-Course Radiotherapy for Prostate Cancer

Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer

A Geospatial Analysis of Disparities in Access to Oncofertility Services

Integrated Clinical-Molecular Classification of Colorectal Liver Metastases

US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020

Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer

Radiosurgery of Spine Metastasis—NRG/RTOG 0631 RCT Final Results

Pathologic Complete Response and Clinical Outcomes in Soft Tissue Sarcoma

Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma

Adoption of Innovative Therapies Across Oncology Practices

Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma

Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA

Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy

Global Association of COVID-19 Pandemic Measures With Cancer Screening

A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief

High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer

Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer

Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy

Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer

Clinical Outcomes and Toxic Effects of Single-Agent ICI Treatment Among Geriatric Patients With Cancer

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer

Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With NSCLC

Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer

Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in ERBB2-Positive Breast Cancer

Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases